Health Affairs, 23, no. 1 (2004): 194-199
doi: 10.1377/hlthaff.23.1.194
© 2004 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via Web of Science (2)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Malkin, J. D.
* Articles by Joyce, G. F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Malkin, J. D.
* Articles by Joyce, G. F.
Related Collections
* Insurance Coverage
* Insurance - Employer-Based System
* Pharmaceuticals

Health Tracking

FROM THE FIELD

The Changing Face Of Pharmacy Benefit Design

Jesse D. Malkin, Dana P. Goldman and Geoffrey F. Joyce

Employers, health plans, and pharmacy benefit managers—seeking to reduce rapid growth in pharmacy spending—have embraced multi-tier pharmacy benefit packages that use differential copayments to steer beneficiaries toward low-cost drugs. The consensus of fifteen pharmacy benefit design experts whom we interviewed is that such plans will become more prevalent and that the techniques these plans use to promote low-cost drugs will intensify. The effect on health outcomes depends on whether the high-cost drugs whose use is being discouraged have close, low-cost substitutes.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?